$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Correct usage, dosage and dosage adjustment standards of eflornithine (IWILFIN)
2026-02-01 22:25:32
Check Details
The latest domestic approval time and application prospects of odevixibat
2026-02-01 22:25:32
Check Details
Comparison of the mechanism of action and clinical effects of donepezil (Aricept) and rivastigmine
2026-02-01 22:25:32
Check Details
Comprehensive analysis of the drug properties, specifications and packaging information of Fidaxomicin
2026-02-01 22:25:32
Check Details
How to safely use ponatinib and dosage adjustment recommendations in patients with hepatic insufficiency
2026-02-01 22:25:32
Check Details
Whether Trelagliptin can cure diabetes and the actual effect of long-term treatment
2026-02-01 22:25:32
Check Details
Possible side effects of Inalisate (Iheli) and scientific countermeasures
2026-02-01 22:25:32
Check Details
Analysis of how long it takes for Abatacept injection to take effect and how long it lasts
2026-02-01 22:25:32
Check Details
What is the approximate price of a box of acotinib/acabrutinib on the market?
2026-02-01 22:25:32
Check Details
New 10-year data shows ibrutinib/Eco has durable efficacy in CLL/SLL
2026-02-01 22:25:32
Check Details
INCB057643 combined with ruxolitinib tablets/ruxolitinib can improve symptoms in patients with myelofibrosis
2026-02-01 22:25:32
Check Details
How long does it take for the skin color to return to its original color after stopping taking Clofazimine/Sempra?
2026-02-01 22:25:32
Check Details
1
2
...
2011
2012
2013
2014
2015
2016
2017
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
SCEMBLIX (Asciminib) Side Effect Management & Special Population Guide
2
Sabril (Vigabatrin) Explained: Indications, Vision Loss Risk & Key Warnings
3
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
4
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
5
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials
6
Dutasteride Soft Capsules: Comprehensive Side Effect Profile and Management Strategies
7
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection
8
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
9
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
10
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
11
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
12
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML